Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | RAF1 | P04049 | 6/20 | 0.49 |
| ▸ | MAP2K1 | Q02750 | 6/20 | 0.49 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6327033 | 0.85 | TRPM8 (0.72) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL6323367 | 0.79 | BCHE (0.61) | KMT2AAPPMTNR1AMTNR1BKDM4E | |
| SCHEMBL6327346 | 0.75 | TRPM8 (0.51) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL14463837 | 0.74 | TRPM8 (0.72) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL14464537 | 0.74 | TRPM8 (0.84) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL6322783 | 0.74 | TRPM8 (0.52) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL6322780 | 0.74 | TRPM8 (0.49) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL6324719 | 0.74 | TRPM8 (0.49) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL6648580 | 0.73 | TRPM8 (0.49) | TRPM8MEN1KMT2ARAF1MAP2K1 | |
| SCHEMBL6327342 | 0.73 | TRPM8 (0.49) | TRPM8MEN1KMT2ARAF1MAP2K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230306-A1 | POLYETHYLENE OR POLYPROPYLENE ARTICLES | BASF SE (DE) | 2025-07-17 | — | — | US | disclosed |
| EP-4308638-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING POLYOLEFIN RECYCLATES, STABILIZER COMPOSITION, MASTER BATCH CONCENTRATE, PLASTIC COMPOSITION, MOLDING COMPOUND OR MOLDING, METHOD FOR STABILIZING A POLYOLEFIN RECYCLATE AND USE OF A PLASTIC COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-01-24 | — | — | EP | disclosed |
| EP-4301810-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING ORGANIC MATERIALS, STABILIZER COMPOSITION, MASTER BATCH, COMPOSITION, MOLDING COMPOUND FOR MOLDINGS, PROCESS FOR OXIDATIVE, THERMAL AND ACTINIC STABILIZATION OF A THERMOPLASTIC, AND USE OF A COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022194672-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING POLYOLEFIN RECYCLATES, STABILIZER COMPOSITION, MASTER BATCH CONCENTRATE, PLASTIC COMPOSITION, MOLDING COMPOUND OR MOLDING, METHOD FOR STABILIZING A POLYOLEFIN RECYCLATE AND USE OF A PLASTIC COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022184687-A1 | USE OF A STABILIZER COMPOSITION FOR STABILIZING ORGANIC MATERIALS, STABILIZER COMPOSITION, MASTER BATCH, COMPOSITION, MOLDING COMPOUND FOR MOLDINGS, PROCESS FOR OXIDATIVE, THERMAL AND ACTINIC STABILIZATION OF A THERMOPLASTIC, AND USE OF A COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-09-09 | — | — | WO | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| US-20050228017-A1 | Novel anticancer compounds | MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE | 2005-10-13 | — | — | US | disclosed |
| US-20050176596-A1 | Alkylaminosiloxanes as corrosion inhibitors | CIBA SPECIALTY CHEMICAL CORP. | 2005-08-11 | — | — | US | disclosed |
| US-6908956-B2 | Stabilizer composition | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-21 | — | — | US | disclosed |
| US-20050049336-A1 | Stabilizer mixtures | GUGUMUS FRANCOIS (CH) | 2005-03-03 | — | — | US | disclosed |
| US-20040241111-A1 | Highly compatible hydroxyphenyltriazine uv-absorbers | CIBA SPECIALTY CHEMICALS CORP. | 2004-12-02 | — | — | US | disclosed |
| EP-1442018-A1 | NOVEL ANTICANCER COMPOUNDS | Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) | 2004-08-04 | — | — | EP | disclosed |
| US-20040058604-A1 | Antistatic flexible intermediate bulk container | CIBA SPECIALTY CHEMICALS CORP. | 2004-03-25 | — | — | US | disclosed |
| US-20030191213-A1 | Novel flame retarding compounds | CIBA SPECIALTY CHEMICALS CORP. | 2003-10-09 | — | — | US | disclosed |
| WO-2003037865-A1 | NOVEL ANTICANCER COMPOUNDS | Morphochem Aktiengesellschaft für kombinatorische Chemie (DE) | 2003-05-08 | — | — | WO | disclosed |
| US-20030060544-A1 | Stabilizer composition | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-27 | — | — | US | disclosed |
| US-20010009939-A1 | STABILIZERS FOR POWDER COATINGS | CIBA SPECIALTY CHEMICALS CORP. | 2001-07-26 | — | — | US | disclosed |
| US-6265473-B1 | STABILIZER; HEAT AND OXIDATION RESISTANCE; PHOTOSTABILITY | CIBA SPECIALTY CHEMICALS CORP. | 2001-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050228017-A1 | Novel anticancer compounds | TP53, ABCG2, MCL1 | TRPM8 2570/4885MEN1 1347/4885KMT2A 3367/4885 |
| US-20040241111-A1 | Highly compatible hydroxyphenyltriazine uv-absorbers | TYR, HAAO, HTT | TRPM8 714/4885MEN1 2757/4885KMT2A 2347/4885 |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | TRPM8 4287/4885MEN1 3754/4885KMT2A 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.